The College of American Pathologists (CAP) has published a new evidence-based guideline designed to bring greater consistency and accuracy to the diagnosis of amyloidosis—a rare but serious condition caused by the accumulation of abnormal amyloid deposits in the body. Earlier and more precise identification is essential for timely treatment, yet diagnosing amyloidosis has long posed challenges for laboratories and pathologists.
For the full article click here: CAP Releases New Evidence-Based Guideline to Standardize Amyloidosis Diagnosis